RU2010129291A - METHOD FOR TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION - Google Patents
METHOD FOR TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION Download PDFInfo
- Publication number
- RU2010129291A RU2010129291A RU2010129291/15A RU2010129291A RU2010129291A RU 2010129291 A RU2010129291 A RU 2010129291A RU 2010129291/15 A RU2010129291/15 A RU 2010129291/15A RU 2010129291 A RU2010129291 A RU 2010129291A RU 2010129291 A RU2010129291 A RU 2010129291A
- Authority
- RU
- Russia
- Prior art keywords
- antibodies
- activated
- angiotensin
- synthase
- endothelial
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Способ лечения и профилактики артериальной гипертензии путем введения в организм лекарственного средства на основе активированной-потенцированной формы сверхмалых доз аффинно очищенных антител к рецептору ангиотензина II, приготовленную путем многократного последовательного разведения и внешнего воздействия, характеризующийся тем, что дополнительно одновременно и сочетано вводят активированную-потенцированную форму сверхмалых доз аффинно очищенных антител к эндотелиальной NO-синтазе. ! 2. Способ по п.1, характеризующийся тем, что используют активированную-потенцированную форму антител к C-концевому фрагменту AT1-рецептора ангиотензина II и активированную-потенцированную форму антител к эндотелиальной NO-синтазе. ! 3. Способ по п.1 или 2, характеризующийся тем, что активированную-потенцированную форму антител к C-концевому фрагменту AT1-рецептора ангиотензина II и активированную-потенцированную форму антител к эндотелиальной NO-синтазе используют в виде активированного-потенцированного водного или водно-спиртового раствора каждого компонента, полученного в процессе последовательного многократного разведения в водном или водно-спиртовом растворителе и промежуточного внешнего механического воздействия - вертикального встряхивания. ! 4. Способ по п.1 или 2, характеризующийся тем, что используют приготовленные в виде единого лекарственного препарата - одной лекарственной формы - смесь различных гомеопатических разведений антител к C-концевому фрагменту AT1-рецептора ангиотензина II в сочетании со смесью различных гомеопатических разведений антител к эндотелиальной NO-синтазе. !5. Способ по п.1 или 2, характер 1. A method for the treatment and prevention of arterial hypertension by introducing into the body a drug based on an activated-potentiated form of ultra-low doses of affinity-purified antibodies to the angiotensin II receptor, prepared by repeated serial dilution and external exposure, characterized in that the activated- potentiated form of ultra-low doses of affinity-purified antibodies to endothelial NO synthase. ! 2. The method according to claim 1, characterized in that they use an activated-potentiated form of antibodies to the C-terminal fragment of the AT1 receptor of angiotensin II and an activated-potentiated form of antibodies to endothelial NO synthase. ! 3. The method according to claim 1 or 2, characterized in that the activated-potentiated form of antibodies to the C-terminal fragment of the AT1 receptor for angiotensin II and the activated-potentiated form of antibodies to endothelial NO synthase are used in the form of an activated-potentiated aqueous or aqueous an alcoholic solution of each component obtained in the course of successive multiple dilutions in an aqueous or hydroalcoholic solvent and an intermediate external mechanical action - vertical shaking. ! 4. The method according to claim 1 or 2, characterized in that use is made of a mixture of different homeopathic dilutions of antibodies to the C-terminal fragment of the AT1 receptor of angiotensin II in combination with a mixture of different homeopathic dilutions of antibodies to those prepared as a single drug - one dosage form endothelial NO synthase. !5. The method according to claim 1 or 2, nature
Claims (11)
Priority Applications (55)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129291/15A RU2525156C2 (en) | 2010-07-15 | 2010-07-15 | Method of treatment and prevention of arterial hypertension and pharmaceutical composition for treatment of arterial hypertension |
US13/135,901 US9308275B2 (en) | 2010-07-15 | 2011-07-15 | Method of increasing the effect of an activated-potentiated form of an antibody |
CA2804969A CA2804969A1 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
AU2011278039A AU2011278039B2 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
AU2011278038A AU2011278038B2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
PE2013000076A PE20130398A1 (en) | 2010-07-15 | 2011-07-15 | A METHOD TO INCREASE THE EFFECT OF AN ACTIVE ENHANCED FORM OF AN ANTIBODY |
EA201300128A EA201300128A1 (en) | 2010-07-15 | 2011-07-15 | COMBINED PHARMACEUTICAL COMPOSITION AND METHODS FOR THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH DISABILITY OF THE CARDIOVASCULAR SYSTEM |
MX2013000543A MX2013000543A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract. |
EEP201300004A EE201300004A (en) | 2010-07-15 | 2011-07-15 | A combined pharmaceutical composition for the treatment of diseases or conditions of the cardiovascular system |
SG10201505561TA SG10201505561TA (en) | 2010-07-15 | 2011-07-15 | A Method Of Increasing The Effect Of An Activated-Potentiated Form Of An Antibody |
KR1020137003520A KR20140009110A (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
SG2013002282A SG187034A1 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
BR112013000840A BR112013000840A2 (en) | 2010-07-15 | 2011-07-15 | method for enhancing the effect of potentiated activated form of antibody to biological endogenous molecule, pharmaceutical composition and use of combination of endogenous biological molecule with potentiated activated form of antibody to endothelial synthase. |
BR112013000779A BR112013000779A2 (en) | 2010-07-15 | 2011-07-15 | combination pharmaceutical compositions, patient treatment methods and use of activated potentiated form of angiotensin ii receptor 1 antibody and activated potentiated form of endothelial synthase antibody |
JP2013519175A JP2013538186A (en) | 2010-07-15 | 2011-07-15 | Method for increasing the effect of activation-enhancing antibodies |
SE1350177A SE1350177A1 (en) | 2010-07-15 | 2011-07-15 | Pharmaceutical combination composition and methods for treating diseases or conditions associated with the cardiovascular system. |
NZ606767A NZ606767A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
DE112011102356T DE112011102356T5 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and method for treating diseases or conditions associated with the cardiovascular system |
JP2013519177A JP2013532183A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and method for treating diseases or conditions associated with the cardiovascular system |
SG2013002324A SG187038A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EP11775838.3A EP2593140A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EA201300126A EA030566B1 (en) | 2010-07-15 | 2011-07-15 | Method of increasing therapeutic effectiveness of an activated-potentiated form of an antibody to an endogenous biological molecule and pharmaceutical composition |
IT000640A ITTO20110640A1 (en) | 2010-07-15 | 2011-07-15 | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM |
MX2013000544A MX2013000544A (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system. |
EP11779851.2A EP2593482A2 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
CZ20130105A CZ2013105A3 (en) | 2010-07-15 | 2011-07-15 | Method of increasing effect of antibody activated potentiated form |
IT000639A ITTO20110639A1 (en) | 2010-07-15 | 2011-07-15 | METHOD TO INCREASE THE EFFECT OF AN ACTIVE-ENHANCED SHAPE OF AN ANTI-BODY |
GB1302649.7A GB2495884B (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
FR1156482A FR2962656A1 (en) | 2010-07-15 | 2011-07-15 | METHOD FOR INCREASING THE EFFECT OF AN ACTIVATED-POTENTIALIZED FORM OF ANTIBODY |
PCT/IB2011/002350 WO2012007845A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
CN2011800443324A CN103108657A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
DE112011102358T DE112011102358T5 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
US13/135,882 US8703124B2 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
PCT/IB2011/002391 WO2012007846A2 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
CA2804966A CA2804966A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
GB1302656.2A GB2496795A (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
UAA201300107A UA114699C2 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
ES201390006A ES2440393R1 (en) | 2010-07-15 | 2011-07-15 | A METHOD FOR INCREASING THE EFFECT OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
SE1350184A SE1350184A1 (en) | 2010-07-15 | 2011-07-15 | PROCEDURE TO INCREASE THE EFFECT OF AN ACTIVATED, POTENTIZED FORM OF AN ANTIBODY |
FR1156474A FR2962654A1 (en) | 2010-07-15 | 2011-07-15 | PHARMACEUTICAL ASSOCIATION COMPOSITION AND USES THEREOF FOR TREATING DISEASES OR DISORDERS ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM |
KR1020137003861A KR20140014059A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EEP201300006A EE201300006A (en) | 2010-07-15 | 2011-07-15 | A pharmaceutical composition for enhancing the effect of an activated and potentiated form of an antibody |
ARP110102578A AR082247A1 (en) | 2010-07-15 | 2011-07-18 | A METHOD FOR INCREASING THE EFFECTS OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
ARP110102577A AR084707A1 (en) | 2010-07-15 | 2011-07-18 | A PHARMACEUTICAL COMBINATION COMPOSITION TO TREAT DISEASES OR CONDITIONS ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM |
CL2013000099A CL2013000099A1 (en) | 2010-07-15 | 2013-01-10 | A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it. |
NO20130217A NO20130217A1 (en) | 2010-07-15 | 2013-02-08 | A pharmaceutical combination composition and methods for treating diseases or conditions associated with the cardiovascular system |
NO20130222A NO20130222A1 (en) | 2010-07-15 | 2013-02-08 | Process for increasing the effect of an activated-potentiated form of an antibody |
DKPA201370080A DK201370080A (en) | 2010-07-15 | 2013-02-14 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
LT2013016A LT5988B (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
DKPA201370079A DK201370079A (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
FI20135145A FI20135145L (en) | 2010-07-15 | 2013-02-15 | Pharmaceutical combination composition and methods for treating diseases or conditions related to the cardiovascular system |
FI20135143A FI20135143L (en) | 2010-07-15 | 2013-02-15 | A method of increasing the potency of an activated potentiated form of an antibody |
US15/060,202 US20160251448A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
US15/060,157 US20160244531A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
JP2016135750A JP2016216483A (en) | 2010-07-15 | 2016-07-08 | Method of increasing effect of activated-potentiated antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129291/15A RU2525156C2 (en) | 2010-07-15 | 2010-07-15 | Method of treatment and prevention of arterial hypertension and pharmaceutical composition for treatment of arterial hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010129291A true RU2010129291A (en) | 2012-01-20 |
RU2525156C2 RU2525156C2 (en) | 2014-08-10 |
Family
ID=45785347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010129291/15A RU2525156C2 (en) | 2010-07-15 | 2010-07-15 | Method of treatment and prevention of arterial hypertension and pharmaceutical composition for treatment of arterial hypertension |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2525156C2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181297C2 (en) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Method of treatment of pathological syndrome and medicinal agent |
RU2201254C1 (en) * | 2001-09-25 | 2003-03-27 | Эпштейн Олег Ильич | Method for treating pathological syndrome and medicinal preparation |
RU2201255C1 (en) * | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Medicinal agent and method of regulation of vascular tonus |
UA40587U (en) * | 2005-06-30 | 2009-04-27 | Иван Николаевич Ермоленко | Pneumo-hydraulic feeding system of propulsion unit |
RU2309732C1 (en) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation |
RU2391980C1 (en) * | 2008-10-22 | 2010-06-20 | Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) | Medication for arterial hypertension and cardiac dysrhythmia treatment |
-
2010
- 2010-07-15 RU RU2010129291/15A patent/RU2525156C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2525156C2 (en) | 2014-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013136350A (en) | PHARMACEUTICAL COMPOSITION CONTAINING OPIOID AGONIST AND SECKED ANTAGONIST | |
RU2010129291A (en) | METHOD FOR TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | |
RU2011127059A (en) | NEUROTROPIC MEDICINE AND METHOD OF TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2011127052A (en) | METHOD FOR TREATING THE HEAD-VARIABLE OF VARIOUS GENESIS, KINETOSIS AND VEGETOVASCULAR DYSTONIA (OPTIONS) AND MEDICINAL PRODUCT | |
RU2011110106A (en) | METHOD FOR TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC HEART FAILURE | |
RU2010129290A (en) | METHOD FOR TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | |
RU2010129292A (en) | METHOD FOR TREATING VEGETAIN VASCULAR DISTONIA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEGETAIN VASCULAR DISTONIA | |
RU2010133053A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL DISEASES AND METHOD OF TREATMENT OF VIRAL DISEASES | |
RU2011127058A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2010133052A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL INFECTIONS AND METHOD OF TREATMENT OF VIRAL INFECTIONS | |
RU2011134414A (en) | FULVIC ACID COMBINATION FOR TREATMENT OF VARIOUS CONDITIONS AND DISEASES | |
RU2010130353A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2010129295A (en) | MEDICINAL PRODUCT FOR TREATING PROSTATE DISEASES AND METHOD FOR TREATING PROSTATE DISEASES | |
RU2010129294A (en) | MEDICINE FOR TREATMENT OF ERECTILE DYSFUNCTIONS AND METHOD OF TREATMENT OF ERECTILE DYSFUNCTIONS | |
RU2013154072A (en) | MEDICINE FOR TREATMENT OF KINETOSIS AND METHOD OF TREATMENT OF KINETOSIS | |
RU2010130358A (en) | MEDICINE FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME AND METHOD FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME | |
RU2010130355A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2013152871A (en) | DIABETES TREATMENT METHOD AND COMBINED MEDICINE | |
RU2013154073A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING A PATHOLOGICAL SYNDROME | |
RU2013154070A (en) | METHOD FOR TREATMENT OF VEGETAIN-VASCULAR DISTONIA AND MEDICINAL PRODUCT | |
RU2010130356A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF VEGETO-VASCULAR DYSTONIA, VERTAIN SYNDROME OF VARIOUS GENESIS AND KINETOSIS | |
RU2010130350A (en) | METHOD FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING AND MEDICINAL PRODUCT FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING | |
RU2010130352A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING ACUTE AND CHRONIC DISEASES OF THE RESPIRATORY SYSTEM AND COUGH SYNDROME | |
RU2013154071A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF HEAD-WAYS | |
RU2011124809A (en) | MEDICINE FOR TREATMENT OF PATHOLOGICAL SYNDROME AND METHOD FOR TREATING FUNCTIONAL INTESTINAL DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130118 |
|
FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20140120 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160716 |